NCT00269763View on ClinicalTrials.gov

Clinical Use and Safety of the Fentanyl Transdermal Therapeutic System (TTS) in the Management of Pain in Patients With Cancer

PHASE3CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

October 31, 1987

Study Completion Date

April 30, 1988

Conditions
PainCancer
Interventions
DRUG

Fentanyl Transdermal Therapeutic System (TTS)

All Listed Sponsors
lead

Alza Corporation, DE, USA

INDUSTRY

NCT00269763 - Clinical Use and Safety of the Fentanyl Transdermal Therapeutic System (TTS) in the Management of Pain in Patients With Cancer | Biotech Hunter | Biotech Hunter